Published in J Am Soc Nephrol on August 01, 1999
IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy. Semin Nephrol (2008) 1.64
Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathy. J Am Soc Nephrol (2012) 1.40
Immunopathogenesis of IgAN. Semin Immunopathol (2007) 1.16
Glycosylation of IgA1 and pathogenesis of IgA nephropathy. Semin Immunopathol (2012) 1.09
Development of immunoglobulin A nephropathy- like disease in beta-1,4-galactosyltransferase-I-deficient mice. Am J Pathol (2007) 1.05
Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: a comparative binding study. Biochemistry (2010) 1.02
New insights into the pathogenesis of IgA nephropathy. Semin Immunopathol (2014) 0.96
Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells. Clin Exp Immunol (2004) 0.95
O-glycosylated IgA rheumatoid factor induces IgA deposits and glomerulonephritis. J Am Soc Nephrol (2011) 0.91
O-linked oligosaccharides of the IgA1 hinge region: roles of its aberrant structure in the occurrence and/or progression of IgA nephropathy. Clin Exp Nephrol (2009) 0.90
Differential binding characteristics of native monomeric and polymeric immunoglobulin A1 (IgA1) on human mesangial cells and the influence of in vitro deglycosylation of IgA1 molecules. Clin Exp Immunol (2007) 0.85
The glycans deficiencies of macromolecular IgA1 is a contributory factor of variable pathological phenotypes of IgA nephropathy. Clin Exp Immunol (2005) 0.83
MPO-ANCA-positive IgA nephropathy successfully treated with tonsillectomy. Clin Exp Nephrol (2007) 0.83
The combined role of galactose-deficient IgA1 and streptococcal IgA-binding M Protein in inducing IL-6 and C3 secretion from human mesangial cells: implications for IgA nephropathy. J Immunol (2014) 0.83
The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy. Front Immunol (2016) 0.83
IgA nephropathy caused by unusual polymerization of IgA1 with aberrant N-glycosylation in a patient with monoclonal immunoglobulin deposition disease. PLoS One (2014) 0.80
A Bitter Sweet Symphony: Immune Responses to Altered O-glycan Epitopes in Cancer. Biomolecules (2016) 0.76
O-linked glycosylation determines the nephritogenic potential of IgA rheumatoid factor. J Am Soc Nephrol (2014) 0.76
Cellular signaling and production of galactose-deficient IgA1 in IgA nephropathy, an autoimmune disease. J Immunol Res (2014) 0.75
The solution structures of native and patient monomeric human IgA1 reveal asymmetric extended structures: implications for function and IgAN disease. Biochem J (2015) 0.75
Aberrant IgA1 Glycosylation in IgA Nephropathy: A Systematic Review. PLoS One (2016) 0.75
Protective role of anti-synthetic hinge peptide antibody for glomerular deposition of hypoglycosylated IgA1. Clin Exp Nephrol (2008) 0.75
Galactosylation of IgA1 Is Associated with Common Variation in C1GALT1. J Am Soc Nephrol (2017) 0.75
Human Cell Line-Derived Monoclonal IgA Antibodies for Cancer Immunotherapy. Bioengineering (Basel) (2017) 0.75
Pharmacokinetics and bactericidal rates of daptomycin and vancomycin in intravenous drug abusers being treated for gram-positive endocarditis and bacteremia. Antimicrob Agents Chemother (1992) 2.57
In vitro pharmacodynamic effects of concentration, pH, and growth phase on serum bactericidal activities of daptomycin and vancomycin. Antimicrob Agents Chemother (1992) 2.43
Kikuchi's disease with liver dysfunction presenting as fever of unknown origin. Lancet (1989) 2.40
Daptomycin compared with teicoplanin and vancomycin for therapy of experimental Staphylococcus aureus endocarditis. Antimicrob Agents Chemother (1990) 2.30
Isolated microscopic haematuria in the genitourinary clinic: the value of renal biopsy. Int J STD AIDS (1997) 2.02
Carbohydrate and the cytokine response to 2.5 h of running. J Appl Physiol (1985) (1997) 1.99
Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients. Kidney Int (2001) 1.99
Treatment of IgA nephropathy. Kidney Int (2006) 1.98
Increased incidence of end-stage renal failure secondary to diabetes mellitus in Asian ethnic groups in the United Kingdom. Diabet Med (1992) 1.79
Glomerular disease as a cause of isolated microscopic haematuria. Q J Med (1994) 1.70
High incidence of end-stage renal disease in Indo-Asians in the UK. QJM (1995) 1.68
Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy. Clin Exp Immunol (1995) 1.66
High incidence of minimal change nephrotic syndrome in Asians. Arch Dis Child (1985) 1.51
Increased immunoglobulin A and immunoglobulin A1 cells in bone marrow trephine biopsy specimens in immunoglobulin A nephropathy. Am J Kidney Dis (1994) 1.50
Parathyroidectomy in chronic renal failure: comparison of three operative strategies. J R Coll Surg Edinb (1996) 1.44
Elevation of IgA in IgA nephropathy is localized in the serum and not saliva and is restricted to the IgA1 subclass. Nephrol Dial Transplant (1993) 1.43
Pathophysiology of cyclosporin A nephrotoxicity: experimental and clinical observations. Nephrol Dial Transplant (1992) 1.43
Pharmacodynamics of once-daily amikacin in various combinations with cefepime, aztreonam, and ceftazidime against Pseudomonas aeruginosa in an in vitro infection model. Antimicrob Agents Chemother (1992) 1.42
The third World Kidney Day: looking back and thinking forward. Clin Nephrol (2008) 1.39
Glucose polymer for ultrafiltration failure in CAPD. Lancet (1993) 1.38
Plasma erythropoietin levels and acquired cystic disease of the kidney in patients receiving regular haemodialysis treatment. Br J Haematol (1991) 1.38
A comparison of the results of renal transplantation from non-heart-beating, conventional cadaveric, and living donors. Kidney Int (2000) 1.35
IgA nephropathy: recent developments. J Am Soc Nephrol (2000) 1.31
Diabetic renal disease: differences between Asian and white patients. Br Med J (Clin Res Ed) (1986) 1.29
Clinical evaluation of teicoplanin fluorescence polarization immunoassay. Antimicrob Agents Chemother (1991) 1.29
CI-960, a new fluoroquinolone, for therapy of experimental ciprofloxacin-susceptible and -resistant Staphylococcus aureus endocarditis. Antimicrob Agents Chemother (1992) 1.26
Leucocyte beta 1,3 galactosyltransferase activity in IgA nephropathy. Nephrol Dial Transplant (1997) 1.21
Abnormal IgA glycosylation in Henoch-Schönlein purpura restricted to patients with clinical nephritis. Nephrol Dial Transplant (1998) 1.19
Enterococcus, an emerging pathogen. Ann Pharmacother (1993) 1.16
Physical exercise in patients with severe kidney disease. Nephron Clin Pract (2010) 1.12
Does the provision of cooled filtered water in secondary school cafeterias increase water drinking and decrease the purchase of soft drinks? J Hum Nutr Diet (2005) 1.12
Acute cholecystitis from metastatic melanoma to the gall-bladder in a patient with a low-risk melanoma. Br J Dermatol (1997) 1.12
Reinforcing doses of diphtheria toxoid in children aged 10 to 12 years. Inadequate response to a single dose of orally administered toxoid. Mon Bull Minist Health Public Health Lab Serv (1966) 1.12
High prevalence of systemic disease and mortality in Asian subjects with systemic lupus erythematosus. Ann Rheum Dis (1991) 1.10
Metabolic activity of erosions in rheumatoid arthritis. Ann Rheum Dis (1986) 1.10
IgA myeloma presenting as Henoch-Schönlein purpura with nephritis. Am J Kidney Dis (2000) 1.06
Cutaneous lymphoid hyperplasia and cutaneous marginal zone lymphoma: comparison of morphologic and immunophenotypic features. Am J Surg Pathol (1999) 1.05
RCPE UK consensus conference statement: Management of acute kidney injury: the role of fluids, e-alerts and biomarkers. J R Coll Physicians Edinb (2013) 1.02
Putative immunolocalization of the mechanoelectrical transduction channels in mammalian cochlear hair cells. Proc Biol Sci (1992) 1.00
Increased dimeric IgA producing B cells in the bone marrow in IgA nephropathy determined by in situ hybridisation for J chain mRNA. J Clin Pathol (1996) 1.00
Antineutrophil cytoplasm antibodies (ANCA) of IgA isotype in adult Henoch-Schönlein purpura. Clin Exp Immunol (1994) 1.00
Systemic vasculitis in the 1980s--is there an increasing incidence of Wegener's granulomatosis and microscopic polyarteritis? J R Coll Physicians Lond (1990) 0.99
A simple radiolabelled rheumatoid factor binding assay for the measurement of circulating immune complexes. J Immunol Methods (1979) 0.99
Glomerular IgA deposition in liver disease. Nephrol Dial Transplant (1999) 0.99
Sequential study of the IgA system in relapsing IgA nephropathy. Kidney Int (1986) 0.98
Modulation of cellular immune function by cyclophosphamide in children with minimal-change nephropathy. N Engl J Med (1984) 0.98
Assessment of the mitogenic potential of the alkaloids produced by endophyte (Acremonium coenophialum)-infected tall fescue (Festuca arundinacea) on bovine vascular smooth muscle in vitro. J Anim Sci (1996) 0.97
Comparison of microscopy, two xenic culture techniques, conventional and real-time PCR for the detection of Dientamoeba fragilis in clinical stool samples. Eur J Clin Microbiol Infect Dis (2010) 0.97
Treatment and outcome of adult patients with primary focal segmental glomerulosclerosis in five UK renal units. QJM (2005) 0.96
Vascular endothelial growth factor mRNA expression in minimal change, membranous, and diabetic nephropathy demonstrated by non-isotopic in situ hybridisation. J Clin Pathol (1999) 0.95
B-cell O-galactosyltransferase activity, and expression of O-glycosylation genes in bone marrow in IgA nephropathy. Kidney Int (2008) 0.95
Gm allotypes in membranous nephropathy. N Engl J Med (1983) 0.94
TIMP-3 mRNA expression is regionally increased in moderately and poorly differentiated colorectal adenocarcinoma. Br J Cancer (1997) 0.94
Expression of J chain mRNA in duodenal IgA plasma cells in IgA nephropathy. Kidney Int (1994) 0.93
The prevalence of diagnosed systemic lupus erythematosus in whites and Indian Asian immigrants in Leicester city, UK. Br J Rheumatol (1992) 0.93
Primary tuberculosis of the esophagus. Am J Gastroenterol (1984) 0.92
The molecular basis of canine pyruvate kinase deficiency. Exp Hematol (1994) 0.92
Is chronic renal transplant rejection a non-immunological phenomenon? Lancet (1986) 0.92
Asymptomatic microscopical haematuria. Br Med J (Clin Res Ed) (1986) 0.91
Correcting impotence in the male dialysis patient: experience with testosterone replacement and vacuum tumescence therapy. Am J Kidney Dis (1998) 0.90
Ofloxacin clinical pharmacokinetics. Clin Pharmacokinet (1992) 0.90
Steroid hormone concentration profiles in healthy intact and neutered dogs before and after cosyntropin administration. Domest Anim Endocrinol (2003) 0.90
The pathogenic role of immunoglobulin A polymers in immunoglobulin A nephropathy. Nephron (1993) 0.89
Increased dimeric IgA-producing B cells in tonsils in IgA nephropathy determined by in situ hybridization for J chain mRNA. Clin Exp Immunol (1995) 0.89
Exaggerated systemic antibody response to mucosal Helicobacter pylori infection in IgA nephropathy. Am J Kidney Dis (1999) 0.89
Outcome of acute renal failure following surgical repair of ruptured abdominal aortic aneurysms. Eur J Vasc Endovasc Surg (2000) 0.89
Increased and prolonged production of specific polymeric IgA after systemic immunization with tetanus toxoid in IgA nephropathy. Clin Exp Immunol (1992) 0.88
A review of zinc phosphide poisoning. Vet Hum Toxicol (1986) 0.88
Renal failure due to cholesterol embolisation. Postgrad Med J (1995) 0.87
Simultaneous in situ hybridisation of native mRNA and immunoglobulin detection by conventional immunofluorescence in paraffin wax embedded sections. J Clin Pathol (1992) 0.86
Absence of "red man syndrome" in patients being treated with vancomycin or high-dose teicoplanin. Antimicrob Agents Chemother (1992) 0.86
Limited genetic diversity among genotypes of Enterocytozoon bieneusi strains isolated from HIV-infected patients from Sydney, Australia. J Med Microbiol (2009) 0.86
Henoch-Schönlein purpura with immunoglobulin A nephropathy and abnormalities of immunoglobulin A in a Wiskott-Aldrich syndrome carrier. Am J Kidney Dis (1997) 0.86
Deterioration in renal function associated with angiotensin converting enzyme inhibitor therapy is not always reversible. J Intern Med (1992) 0.85
Iga nephropathy, antineutrophil cytoplasmic antibodies and crescentic glomerulonephritis in a patient with the Hermansky-Pudlak syndrome. Am J Nephrol (2001) 0.85
Rate of decline in renal function in Indo-Asians and Whites with diabetic nephropathy. Diabet Med (1998) 0.85
Effect of recombinant human erythropoietin on erythropoiesis in homozygous sickle-cell anaemia and renal failure. Nephrol Dial Transplant (1992) 0.85
Systemic and mucosal IgA responses to systemic antigen challenge in IgA nephropathy. Clin Immunol Immunopathol (1993) 0.85
Recurrent acute renal failure with interstitial nephritis due to D-penicillamine. Ren Fail (1987) 0.85
Infective endocarditis-associated glomerulonephritis in rabbits: evidence of a pathogenetic role for antiglobulins. Clin Exp Immunol (1981) 0.84
The new Oxford Clinico-Pathological Classification of IgA nephropathy. Prilozi (2010) 0.84
Effect of nifedipine on renal haemodynamics in an animal model of cyclosporin A nephrotoxicity. Clin Sci (Lond) (1990) 0.84
Thermal injury in rats alters glucose utilization by skin, wound, and small intestine, but not by skeletal muscle. Metabolism (1996) 0.84
Expression of the mucosal gamma delta T cell receptor V region repertoire in patients with IgA nephropathy. Kidney Int (1997) 0.83
High risk acute renal failure. Q J Med (1986) 0.83
Identification of a novel Fcalpha receptor expressed by human mesangial cells. Kidney Int (2000) 0.83
A quantitative study comparing adjustment and acceptance of illness in adults on renal replacement therapy. ANNA J (1999) 0.83
In vitro immunoglobulin isotype suppression in immunoglobulin A nephropathy. Exp Nephrol (1994) 0.82
A comparative study of digoxigenin, 2,4-dinitrophenyl, and alkaline phosphatase as deoxyoligonucleotide labels in non-radioisotopic in situ hybridisation. J Clin Pathol (1997) 0.82
Increasing frequency of adult IgA nephropathy in the UK? Lancet (1987) 0.82
Listeria monocytogenes peritonitis complicating CAPD. Perit Dial Int (1989) 0.82
The effect of nifedipine on renal function in normotensive cyclosporin-A-treated renal allograft recipients. Nephrol Dial Transplant (1990) 0.82